xmlui.themes.about.link
Departamento de Medicina y Psiquiatría: Envíos recientes
Mostrando ítems 721-740 de 1366
-
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
(Tokyo Japanese Cancer Association, 2022-11-12) -
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study
(Oxford University Press, 2022-10) -
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia
(American Society of Hematology, 2023-01-10) -
Exploring the relationship between deficits in social cognition and neurodegenerative dementia: a systematic review
(Frontiers Research Foundation, 2022-04) -
Clinical experience of cefiderocol
(Sociedad española de quimioterapia, 2022-10) -
High Bone Mass Disorders: New Insights from Connecting the Clinic and the Bench
(John Wiley & Sons, 2022-09) -
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
(European Respiratory Society, 2022) -
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
(John Wiley & Sons Ltd, 2022-09-20) -
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
(Oxford University Press, 2022) -
Natural History of MYH7-related Dilated Cardiomyopathy
(Elsevier, 2022-08-22) -
Pacientes con inmunización frente a SARS-CoV-2 que han requerido ingreso hospitalario por neumonía COVID-19 en un hospital comarcal (Sierrallana-Cantabria)
(Sociedad española de quimioterapia, 2022-10) -
TNF inhibitors exert a "hidden" beneficial effect in the cardiovascular lipoprotein profile of RA patients
(Dove Medical Press, 2022-10) -
Pacientes con inmunización frente a SARS-CoV-2 que han requerido ingreso hospitalario por neumonía COVID-19 en un hospital comarcal (Sierrallana-Cantabria)
(Sociedad española de quimioterapia, 2022-10)







